Eaton Vance Management’s Cantel Medical Corporation CMD Stock Holding History

Eaton Vance Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-24,749	Closed	-$1.98M	–	3133
2021 Q1	$1.98M	Buy	24,749 +140	+0.6%	+$10.9K	﹤0.01%	978
2020 Q4	$1.94M	Hold	24,609	–	–	﹤0.01%	934
2020 Q3	$1.08M	Hold	24,609	–	–	﹤0.01%	969
2020 Q2	$1.09M	Sell	24,609 -7	-0%	-$261	﹤0.01%	945
2020 Q1	$884K	Hold	24,616	–	–	﹤0.01%	940
2019 Q4	$1.75M	Hold	24,616	–	–	﹤0.01%	864
2019 Q3	$1.84M	Buy	24,616 +13,960	+131%	+$1.18M	﹤0.01%	826
2019 Q2	$859K	Hold	10,656	–	–	﹤0.01%	995
2019 Q1	$713K	Hold	10,656	–	–	﹤0.01%	998
2018 Q4	$793K	Buy	10,656 +7	+0.1%	+$578	﹤0.01%	918
2018 Q3	$980K	Hold	10,649	–	–	﹤0.01%	914
2018 Q2	$1.05M	Sell	10,649 -10,649	-50%	-$1.19M	﹤0.01%	868
2018 Q1	$2.37M	Buy	21,298 +10,567	+98%	+$1.18M	﹤0.01%	812
2017 Q4	$1.1M	Buy	+10,731	New	+$1.07M	﹤0.01%	816

Eaton Vance Management's CMD Position: Q2 2021 in Review

Eaton Vance Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 24,749 shares — an estimated $1.98M sold.

Eaton Vance Management first reported a position in CMD in Q4 2017 and held it in 14 quarters. The position peaked at $2.37M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Eaton Vance Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Eaton Vance Management sold 24,749 Cantel Medical Corporation shares in Q2 2021, an estimated $1.98M.
Eaton Vance Management first reported a position in Cantel Medical Corporation in Q4 2017 and held it in 14 quarters.
Eaton Vance Management's Cantel Medical Corporation position peaked at $2.37M in Q1 2018.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Eaton Vance Management's 13F filing for Q2 2021, filed 16 Aug 2021.